$28.500
-0.376 (-1.32%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
LKFT 相似圖表分析預測
Alphio's LKFT stock price prediction model matches the current Lakefront Biotherapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.20 (-1.04%). The 1-week path is $26.91 (-5.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Lakefront Biotherapeutics NV 股票嗎?
Lakefront Biotherapeutics appears to be a good buy right now due to its recent positive developments and favorable financial metrics. The current price is $28.88, which is below the analyst's revised price target of $26, indicating potential upside. The company has a strong gross margin of 99.95% reported in Q4 2025, and its recent FDA Orphan Drug Designation for Gamgertamig enhances its market potential. However, the main risk is the high forward P/E ratio of 344.83, indicating that the stock may be overvalued if growth does not materialize as expected.
LKFT 股價於 Monday 收在 $28.50,此前下跌 -1.32%
Lakefront Biotherapeutics NV (LKFT) last closed at $28.5, losing -1.32%. These facts feed the 1-day and 1-week LKFT price prediction above.
預測驅動因素
Lakefront Biotherapeutics NV(LKFT)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 LKFT 最接近的股票,依相似度排序。
LKFT 季節性分析
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。